Menu
Recruiting NCT07124520

Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, An Unblinded: Randomized Pilot Study

No phase Interventional Tongue Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Iowa Oral Performance Instrument (IOPI).
Who it may be relevant to
Registry conditions: Tongue Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to learn more about tongue strength and endurance by using the Iowa Oral Performance Instrument (IOPI). The IOPI is a device that measures tongue pressure.

Interventions

  • Device Iowa Oral Performance Instrument (IOPI)
    The Iowa Oral Performance Instrument/IOPI is an instrument that objectively measures tongue strength using a standard-sized air-filled bulb. An individual presses the bulb against the roof of the mouth with the tongue to generate a pressure measurement in kilopascals (kPa). Maximum tongue strength can be determined using a measure of pressure.

Primary outcome measures

  • Tongue strength as measured by Iowa Oral Performance Instrument/IOPI [Time frame: Up to 6 months]
  • Endurance as measured by Iowa Oral Performance Instrument/IOPI [Time frame: Up to 6 months]

Eligibility criteria

Inclusion criteria

  • Age ≥18 years old
  • Scheduled to undergo primary surgery for oral tongue cancer (glossectomy types 1 to 3) using any type of closure or reconstruction

Exclusion criteria

  • Previous radiation therapy to the oral cavity or head and neck
  • Previous surgery for oral cavity cancer
  • Recurrent oral cavity cancer
  • Surgical requirement of extension to involve bone (mandible resection)
  • Subtotal or total glossectomy
  • Feeding tube dependance prior to surgery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 7 centers
  • Memorial Sloan Kettering at Basking Ridge (Consent only) — Basking Ridge
  • Memoral Sloan Kettering Monmouth (Consent only) — Middletown
  • Memorial Sloan Kettering Bergen (Consent Only) — Montvale
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) — Commack
  • Memoral Sloan Kettering Westchester (Consent only) — Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites) — New York
  • Memorial Sloan Kettering Cancer Center @ Nassau (Consent only) — Uniondale

Identifiers

NCT: NCT07124520 · 25-162

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗